ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Lincoln Pharmaceuticals has dispatched physical letters to shareholders with unregistered email IDs to provide access to the Annual Report for FY 2025-26 and facilitate KYC updates.
Lincoln Pharmaceuticals submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory adherence with no major non-compliances.
Lincoln Pharmaceuticals Ltd confirmed it does not meet the SEBI criteria for 'Large Corporate' classification for FY 2025-26. The company reported zero outstanding long-term borrowings and zero mandatory debt sourcing requirements for the period, maintaining its status as a mid-sized corporate entity for regulatory purposes.